-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA finds no bioequivalence deficiencies in NRX Pharmaceuticals’ preservative-free ketamine ANDA review

Reuters·03/17/2026 11:02:58

Please log in to view news